Cryptocurrency constantly influences the decision-making of major companies around the world

Equillium incorporates cryptocurrencies into its financial strategy to address cash concerns

Equillium announced it will integrate cryptocurrencies into its financial reserve strategy as the biotech company seeks to diversify its financial assets amid limited cash flow

The La Jolla, California-based company, which develops treatments for autoimmune and inflammatory diseases, said its board of directors approved the inclusion of digital currencies in its financial investment policy after an industry review. CEO Bruce Steele said the strategy aims to provide shareholders with diversification, liquidity, and capital appreciation potential.

Equillium reported cash and cash equivalents of approximately $11.5 million. Based on implemented cost-cutting measures and ongoing cash conservation efforts, the company plans to provide an update on its cryptocurrency strategy in the third quarter of 2025. The company expects its existing cash to fund operations through the fourth quarter of 2025.

Jeffs’ Brands plans to raise up to $75 million to launch AI-driven crypto finance strategy program

The treasury program will be managed by Quantum Crypto Assets Treasury Management Ltd. (“Quantum Crypto”), a subsidiary of Tectona Ltd., one of Israel’s largest public cryptocurrency companies

Strategy reported that the company purchased 21,021 Bitcoins for $2.46 billion

According to company filings, Strategy (MSTR) acquired 21,021 bitcoins between July 28 and August 5, 2025, for a total purchase price of $2.46 billion and an average price of $117,256 per bitcoin.